NEW YORK (AP) _ Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $5.6 million in its fiscal first quarter.

The New York-based company said it had a loss of 23 cents per share.

The drug maker posted revenue of $674,000 in the period.

The company's shares closed at $4.46. A year ago, they were trading at $5.29.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News